Richard Bayliss

Prof. Dr. Richard Bayliss

Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2003 in Molecular Cell
Verified
Journal Article
Closed access
RBRichard Bayliss
Richard Bayliss
TSTeresa Sardon
Teresa Sardon
IVIsabelle Vernos
Isabelle Vernos
ECElena Conti
Elena Conti

1 July 2000 in Cell
Verified
Journal Article
Closed access
RBRichard Bayliss
Richard Bayliss
TLTrevor Littlewood
Trevor Littlewood
MSMurray Stewart
Murray Stewart

1 January 2012 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
AFAndrew Fry
Andrew Fry
LOLaura O'Regan
Laura O'Regan
SSSarah Sabir
Sarah Sabir
RBRichard Bayliss
Richard Bayliss
Genetic screens for cell division cycle mutants in the filamentous fungus Aspergillus nidulans led to the discovery of never-in-mitosis A (NIMA), a serine/threonine kinase that is required for mitotic entry. Since that discovery, NIMA-related kinases, or NEKs, have been identified in most eukaryotes, including humans where eleven genetically distinct proteins named NEK1 to NEK11 are expressed. Although there is no evidence that human NEKs are essential for mitotic entry, it is clear that several NEK family members have important roles in cell cycle control. In particular, NEK2, NEK6, NEK7 and NEK9 contribute to the establishment of the microtubule-based mitotic spindle, whereas NEK1, NEK10 and NEK11 have been implicated in the DNA damage response. Roles for NEKs in other aspects of mitotic progression, such as chromatin condensation, nuclear envelope breakdown, spindle assembly checkpoint signalling and cytokinesis have also been proposed. Interestingly, NEK1 and NEK8 also function within cilia, the microtubule-based structures that are nucleated from basal bodies. This has led to the current hypothesis that NEKs have evolved to coordinate microtubule-dependent processes in both dividing and non-dividing cells. Here, we review the functions of the human NEKs, with particular emphasis on those family members that are involved in cell cycle control, and consider their potential as therapeutic targets in cancer.

1 June 2015 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
DRDaniel T Rogerson
Daniel T Rogerson
ASAmit Sachdeva
Amit Sachdeva
KWKaihang Wang
Kaihang Wang
THTamanna Haq
Tamanna Haq
AKAgne Kazlauskaite
Agne Kazlauskaite
JCJason W Chin
Jason W Chin

10 July 2022 in Journal of Biological Chemistry
Verified
Journal Article
Open access
CAChris Arter
Chris Arter
LTLuke Trask
Luke Trask
SWSarah Ward
Sarah Ward
SYSharon Yeoh
Sharon Yeoh
RBRichard Bayliss
Richard Bayliss
Protein kinases are key components in cellular signaling pathways as they carry out the phosphorylation of proteins, primarily on Ser, Thr, and Tyr residues. The catalytic activity of protein kinases is regulated, and they can be thought of as molecular switches that are controlled through protein–protein interactions and post-translational modifications. Protein kinases exhibit diverse structural mechanisms of regulation and have been fascinating subjects for structural biologists from the first crystal structure of a protein kinase over 30 years ago, to recent insights into kinase assemblies enabled by the breakthroughs in cryo-EM. Protein kinases are high-priority targets for drug discovery in oncology and other disease settings, and kinase inhibitors have transformed the outcomes of specific groups of patients. Most kinase inhibitors are ATP competitive, deriving potency by occupying the deep hydrophobic pocket at the heart of the kinase domain. Selectivity of inhibitors depends on exploiting differences between the amino acids that line the ATP site and exploring the surrounding pockets that are present in inactive states of the kinase. More recently, allosteric pockets outside the ATP site are being targeted to achieve high selectivity and to overcome resistance to current therapeutics. Here, we review the key regulatory features of the protein kinase family, describe the different types of kinase inhibitors, and highlight examples where the understanding of kinase regulatory mechanisms has gone hand in hand with the development of inhibitors.

1 December 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
RBRichard Bayliss
Richard Bayliss
TLTrevor Littlewood
Trevor Littlewood
LSLisa A. Strawn
Lisa A. Strawn
SWSusan R. Wente
Susan R. Wente
MSMurray Stewart
Murray Stewart
The interaction between nuclear pore proteins (nucleoporins) and transport factors is crucial for the translocation of macromolecules through nuclear pores. Many nucleoporins contain FG sequence repeats, and previous studies have demonstrated interactions between repeats containing FxFG or GLFG cores and transport factors. The crystal structure of residues 1-442 of importin-beta bound to a GLFG peptide indicates that this repeat core binds to the same primary site as FxFG cores. Importin-beta-I178D shows reduced binding to both FxFG and GLFG repeats, consistent with both binding to an overlapping site in the hydrophobic groove between the A-helices of HEAT repeats 5 and 6. Moreover, FxFG repeats can displace importin-beta or its S. cerevisiae homologue, Kap95, bound to GLFG repeats. Addition of soluble GLFG repeats decreases the rate of nuclear protein import in digitonin-permeabilized HeLa cells, indicating that this interaction has a role in the translocation of carrier-cargo complexes through nuclear pores. The binding of GLFG and FxFG repeats to overlapping sites on importin-beta indicates that functional differences between different repeats probably arise from differences in their spatial organization.